Endpoints News 生物医药· Max Gelman·· 16 天前AI 评分29
Sanofi 停止开发 Nurix 的 STAT6 蛋白降解药物
Sanofi ends development of Nurix's STAT6 degrader
AI 导读
Sanofi 终止了一款针对 STAT6 蛋白的实验药物开发,该药物被视为下一代免疫学治疗的潜在基石。
正文
Sanofi is dropping an experimental drug targeting a pathway that many analysts see as a potential pillar of the next generation of immunology medicine.
The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news